Invention Grant
US08398987B2 Use of platelet glycopeptide IIIa epitopes in the treatment of immune thrombocytopenic purpura
有权
使用血小板糖肽IIIa表位治疗免疫性血小板减少性紫癜
- Patent Title: Use of platelet glycopeptide IIIa epitopes in the treatment of immune thrombocytopenic purpura
- Patent Title (中): 使用血小板糖肽IIIa表位治疗免疫性血小板减少性紫癜
-
Application No.: US12523549Application Date: 2008-01-18
-
Publication No.: US08398987B2Publication Date: 2013-03-19
- Inventor: Stanislaw Joseph Urbaniak , Robert Norman Barker , Hosea Sukati
- Applicant: Stanislaw Joseph Urbaniak , Robert Norman Barker , Hosea Sukati
- Applicant Address: GB Aberdeen GB Edinburgh
- Assignee: The University Court of the University of Aberdeen,The Common Services Agency for the Scottish Health Service
- Current Assignee: The University Court of the University of Aberdeen,The Common Services Agency for the Scottish Health Service
- Current Assignee Address: GB Aberdeen GB Edinburgh
- Agency: Licata & Tyrrell P.C.
- Priority: GB0701048.1 20070118
- International Application: PCT/EP2008/050595 WO 20080118
- International Announcement: WO2008/087216 WO 20080724
- Main IPC: A61K39/00
- IPC: A61K39/00
Abstract:
The present invention relates to a composition for treating diseases associated with autoantibodies specific for platelet proteins, in particular autoimmune thrombocytopenic purpura. The composition, comprising an epitope of a platelet protein, treats diseases by tolerization.
Public/Granted literature
- US20100086562A1 Use of Platelet Glycopeptide IIIA Epitopes in the Treatment of Immune Thrombocytopenic Purpura Public/Granted day:2010-04-08
Information query
